Many people taking Ozempic for weight loss or Wegovy for diabetes management have reported vivid, intense dreams and nightmares as a side effect of the semaglutide medications.

Wegovy is a brand-name subcutaneous injection prescribed for weight loss and reduction of cardiovascular risks. Its cost with and without insurance can depend on several factors, such as whether ...

Direct-to-consumer pharmaceutical startup Hims & Hers Health said it is selling injectable GLP-1 weight loss drugs for a fraction of the cost of brand-name competitors such as Wegovy and Ozempic.

Wegovy (semaglutide) is an FDA-approved medication for chronic weight management. Learn more about Wegovy, including how it works and potential risks.

FILE PHOTO: Wegovy maker Novo Nordisk said it will cut the price of the weight-loss medication to $199 for one month for new customers. The move comes as the FDA phases out compounded versions of ...

As of May 22, manufacturers are no longer allowed to distribute the compounded versions of semaglutide, which Novo Nordisk sells under the brand Wegovy for weight loss and Ozempic for diabetes.

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications. Clinical ...

The hugely popular medications Ozempic and Wegovy , used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.

Novo Nordisk, the maker of Wegovy, announced exclusively on "Good Morning America" Tuesday that the medication will soon be available for purchase through the telehealth companies Ro, Hims and ...

The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients in a major clinical trial, according to the findings published Wednesday in the New England ...

Novo Nordisk will cut the price of its blockbuster weight loss medication Wegovy to $499 per month for certain patients who pay using their own money instead of going through insurance, the drug ...

In 2024, Wegovy was also approved to help lower the risk of death due to heart disease, heart attack, and stroke in adults with known heart conditions who also have excess weight or obesity.